Synlett 2019; 30(17): 2000-2003
DOI: 10.1055/s-0039-1690183
letter
© Georg Thieme Verlag Stuttgart · New York

Efficient Halogenation of 2-Aminopyrazine

Enric Lizano
,
Josep Grima
,
M. Dolors Pujol
Laboratori de Química Farmacèutica, Facultat de Farmàcia i Ciències de l’Alimentació, University of Barcelona, Campus Diagonal, Av. Joan XXIII, 27–31, 08028 Barcelona, Spain   Email: mdpujol@ub.edu
› Author Affiliations
Further Information

Publication History

Received: 27 June 2019

Accepted after revision: 02 August 2019

Publication Date:
11 September 2019 (online)


Abstract

2-Aminopyrazine was halogenated with NIS, NCS, and NBS under different reaction conditions. Chlorination and bromination were achieved with good yields by using acetonitrile as the solvent. However, iodination was only obtained in poor yields. Undoubtedly, the best conditions for both mono- and dihalogenation were the use of NBS, acetonitrile, and microwave assistance for short periods. 3,5-Dibromo-2-aminopyrazine is an excellent functionalized starting material for the synthesis of nitrogen heterocycles.

Supporting Information

 
  • References

  • 1 Vitaku E, Smith DT, Njardarson JT. J. Med. Chem. 2014; 57: 10257
    • 2a Trump DL, Payne H, Miller K, Bono JS, Stephenson J, Burris HA, Nathan F, Taboada M, Morris T, Hubner A. Prostate 2011; 71: 1264
    • 2b Lida K, Itoh K, Kumagai Y, Oyasu R, Hattori K, Kawai K, Shimazui T, Akaza H, Yamamoto M. Cancer Res. 2004; 64: 6424
  • 3 Revill P, Serradell N, Bolos J, Rosa E. Drugs Future 2007; 32: 788
  • 4 Da Silva YK, Augusto CV, de Castro Barbosa ML, de Albuquerque melo GM, de Queiroz AC, de Lima Matos Freire Dias T, Junior WB, Barreiro EJ, Alezxandre-Moreira MS. Bioorg. Med. Chem. 2010; 18: 5007
    • 5a Nikishkin NI, Huskens J, Verboom W. Org. Biomol. Chem. 2013; 11: 3583
    • 5b Littke AF, Fu C. Angew. Chem. Int. Ed. 2002; 41: 4176
  • 6 Beak P, Musick TJ, Chen CW. J. Am. Chem. Soc. 1988; 110: 3538
  • 7 Barton D, Ollis WD. Comprehensive Organic Chemistry, Vol. 4. Sammes PA. Pergamon Press; Oxford: 1979
    • 8a De Bie DA, Ostrowitcz A, Geurtsen G, Van der Plas HC. Tetrahedron 1988; 44: 2977
    • 8b Sato N, Takeuchi R. Synthesis 1990; 659
    • 8c Sato N. J. Heterocycl. Chem. 1982; 19: 673
  • 9 Younis Y, Douelle F, González-Cabrera D, Le Manach C, Nchinda AT, Paquet T, Street LJ, White KL, Zabiulla M, Joseph JT, Bashyam S, Waterson D, Witty MJ, Wittlin S, Charman SA, Chibale K. J. Med. Chem. 2013; 56: 8860
  • 10 Le Manach C, Nchinda AT, Paquet T, Gonzàlez-Cabrera D, Younis Y, Han Z, Bashyam S, Zabiulla M, Taylor D, Lawrence N, White KL, Charman SA, Waterson D, Witty MJ, Wittlin S, Botha ME, Nondaba SH, Reader J, Birkholtz L.-M, Jiménez-Díaz MB, Santos-Martínez M, Ferrer S, Angulo-Barturen I, Meister S, Antonova-Koch Y, Winzeler EA, Street L, Chibale JK. J. Med. Chem. 2016; 59: 9890
  • 11 Chou C.-M, Tung Y.-W, Ling M.-I, Chan D, Phakhodee W, Isobe M. Heterocycles 2012; 86: 1323
  • 12 Brachwitz H. J. Prakt. Chem. 1969; 311: 40
  • 13 Martínez-González S, Hernández AI, Varela C, Rodríguez-Arístegui S, Pastor J. Bioorg. Med. Chem. Lett. 2012; 22: 1874
  • 14 Zimmermann PJ, Brehm C, Buhr W, Palmer AM, Simon W.-A. Bioorg. Med. Chem. 2008; 16: 536
  • 15 Itho T, Kato S, Nonoyama N, Wada T, Maeda K, Mase T, Zhao MM, Song JZ, Tschaen DM, McNamara JM. Org. Process Res. Dev. 2006; 10: 822
    • 16a Jiang B, Yang C.-G, Xiong W.-N, Wang J. Bioorg. Med. Chem. 2001; 9: 1149
    • 16b Goel R, Luxami V, Paul K. R.S.C. Adv. 2014; 4: 9885
  • 17 Caldwell JJ, Veillard N, Collins I. Tetrahedron 2012; 68: 9713
  • 18 Halogenation; General ProcedureTo a solution of pyrazine-2-amine (1.0 mmol) in methanol, acetonitrile, dimethylformamide, or lithium diisopropylethylamine (5–10 mL) was added N-iodosuccinimide (NIS) (procedure A) (1.1–3.0 mmol) or I2 (1.1 mmol) or N-chlorosuccinimide (NCS) (procedure B) or N-bromosuccinimide (NBS) (procedure C) [in the reaction with I2 also LDA (1.5 mmol) was added]. The reaction mixture was stirred until no starting material could be detected by thin-layer chromatography. Then, the solvent was removed under reduced pressure to give the crude product, which was purified by silica gel column chromatography.Reaction under Microwave Irradiation; General ProcedureTo a solution of the pyrazine-2-amine (1.0 mmol) in acetonitrile (5 mL) in a glass tube (10 mL) sealed with a silicon septum was added N-iodosuccinimide (NIS) (procedure A) (1.1–3.0 mmol) or I2 (1.1 mmol) or N-chlorosuccinimide (NCS) (procedure B) or N-bromosuccinimide (NBS) (procedure C) (1.1–2.2 mmol) containing magnetic stirring. The tube was introduced to the microwave oven, heated to 100 °C, and subjected to a variable MW power until 300 W (an IR sensor measured the temperature of the glass tube surface) until no starting material could be detected by thin-layer chromatography. Then, the solvent was removed under reduced pressure to give the crude product, which was purified by silica gel column chromatography. Alternatively, the crude reaction mixture can be extracted with diethyl ether/water (3×15 mL), dried with sodium sulfate, filtered, and the solvent can be removed to dryness. Representative product:2-Amino-3,5-dibromopyrazine 1H NMR (400 MHz, CDCl3): δ = 5.18 (br s, 2 H, NH2), 8.04 (s, 1 H, H-6). 13C NMR (100.6 MHz, CDCl3): δ = 123.6 (C3), 124.0 (C5), 143.1 (CH, C6), 151.9 (C2). Mp: 118–120 °C (Lit.16amp 117–118 °C).